These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15568146)

  • 21. Pharmacological therapy of atrial fibrillation.
    Patton KK; Page RL
    Expert Opin Investig Drugs; 2007 Feb; 16(2):169-79. PubMed ID: 17243937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial fibrillation: mechanistic insights and treatment options.
    Mathew ST; Patel J; Joseph S
    Eur J Intern Med; 2009 Nov; 20(7):672-81. PubMed ID: 19818285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.
    Aguilar M; Rose RA; Takawale A; Nattel S; Reilly S
    Cardiovasc Res; 2021 Jun; 117(7):1645-1661. PubMed ID: 33723575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial structural remodeling as an antiarrhythmic target.
    Burstein B; Nattel S
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology and therapy of atrial fibrillation].
    Capucci A; Aschieri D; Villani GQ
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left atrial flow velocity distribution and flow coherence using four-dimensional FLOW MRI: a pilot study investigating the impact of age and Pre- and Postintervention atrial fibrillation on atrial hemodynamics.
    Fluckiger JU; Goldberger JJ; Lee DC; Ng J; Lee R; Goyal A; Markl M
    J Magn Reson Imaging; 2013 Sep; 38(3):580-7. PubMed ID: 23292793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic Drug Therapy for Atrial Fibrillation.
    Sardar MR; Saeed W; Kowey PR
    Heart Fail Clin; 2016 Apr; 12(2):205-21. PubMed ID: 26968666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation: mechanisms, therapeutics, and future directions.
    Pellman J; Sheikh F
    Compr Physiol; 2015 Apr; 5(2):649-65. PubMed ID: 25880508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
    Nattel S
    Cardiovasc Res; 2002 May; 54(2):347-60. PubMed ID: 12062340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
    Nattel S
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of mitral valve repair/replacement surgery on atrial arrhythmia behavior.
    Raine D; Dark J; Bourke JP
    J Heart Valve Dis; 2004 Jul; 13(4):615-21. PubMed ID: 15311868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.
    Talajic M; Roy D
    Can J Cardiol; 2005 Sep; 21 Suppl B():19B-25B. PubMed ID: 16239983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary approaches to persistent atrial fibrillation.
    Manlucu J; Brancato S; Lane C; Kazemian P; Michaud GF
    Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1421-35. PubMed ID: 23244363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New pharmacological approaches to atrial fibrillation.
    Milnes JT; Madge DJ; Ford JW
    Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.